regulatory
confidence high
sentiment neutral
materiality 0.50
INTELLIGENT BIO SOLUTIONS INC. (INBS): Nasdaq/NYSE listing notice — INBS regains Nasdaq compliance on stockholders' equity, but faces ongoing monitoring
INTELLIGENT BIO SOLUTIONS INC.
- Nasdaq confirmed compliance with $2.5M min. equity requirement after INBS reported $4.24M equity as of Oct 31, 2023.
- Equity increase primarily from public offering that closed Oct 4, 2023.
- Nasdaq warned that failure to maintain compliance in next 10-Q (Dec 31, 2023) could lead to delisting.
- Company still does not meet alternative listing standards (market value of $35M or net income of $500K).